Physician profile
Terrance A Riske
NPI 1932182110
$1,241.12
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $89.69 · 2022: $34.38 · 2023: $541 · 2024: $37.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.98 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $205.14 | 2019-2023 | Qulipta, Ubrelvy, Vraylar |
| Horizon Therapeutics Plc | $202.87 | 2019-2020 | |
| Astellas Pharma US INC | $147.16 | 2019-2023 | Veozah |
| Pfizer INC. | $144.21 | 2019-2024 | |
| Amgen INC. | $129.88 | 2019-2024 | Prolia, Evenity, Otezla |
| Novartis Pharmaceuticals Corporation | $87.92 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.74 | 2020-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $53.27 | 2019-2023 | Spravato |
| Exact Sciences Corporation | $46.39 | 2023 | Cologuard Collection Kit |
| Pacira Therapeutics, INC. | $44.47 | 2019 | |
| Merck Sharp & Dohme LLC | $26.46 | 2019 | |
| Hologic Sales and Service, LLC | $18.31 | 2019 | |
| Strongbridge US INC. | $14.94 | 2019 | |
| Lilly USA, LLC | $14.78 | 2023 | Mounjaro |
| Medtronic Vascular, INC. | $13.37 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.00 | 2020 | |
| Quidel Corporation | $5.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrance Riske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.